Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2021-03-10 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issuance of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, specifically Regulation 39(3). The content is about share certificate replacement and does not contain financial data, earnings, management changes, or meeting materials. It is an official regulatory communication related to shareholding records but does not fit into categories like share issue, director dealings, or voting results. Given the nature and length of the document, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-10 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is an announcement of a specific event related to share certificates, not a financial report, management change, or other detailed filing. The document is short (1125 characters) and serves as a notification to regulatory bodies. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-08 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is an announcement of a specific event related to share certificates, not a financial report, management change, or other detailed filing. The document length is short (1125 characters), and it serves as a notification to the exchanges. This fits the category of Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-08 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is a notification about a specific event related to share certificates, not a financial report, meeting material, or management discussion. The content is brief (1150 characters) and serves as an official regulatory disclosure. This fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2021-03-04 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, referencing SEBI regulations. It is an announcement about a specific event related to share certificates, not a financial report, management change, or other detailed filing. The content is brief (1150 characters) and serves as a notification to regulatory bodies. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-03-04 English
Updates
Report Publication Announcement Classification · 95% confidence The document contains a letter dated 2nd March 2021 addressed to stock exchanges regarding the publication of a Notice to Shareholders. It mentions the notice was published in newspapers and encloses copies of the notice. The content includes various unrelated news articles and announcements, but the key regulatory content is the publication of the Notice to Shareholders. There is no detailed financial data, management discussion, or full report text. The document is relatively short and serves as an announcement that the Notice to Shareholders has been published, rather than the Notice itself or a full report. Therefore, it fits the category of Report Publication Announcement (RPA).
2021-03-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.